• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病肾病中肾小管细胞损伤机制的最新进展

Update on the Mechanisms of Tubular Cell Injury in Diabetic Kidney Disease.

作者信息

Chang Jingsheng, Yan Jiayi, Li Xueling, Liu Ni, Zheng Rong, Zhong Yifei

机构信息

Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

出版信息

Front Med (Lausanne). 2021 Mar 30;8:661076. doi: 10.3389/fmed.2021.661076. eCollection 2021.

DOI:10.3389/fmed.2021.661076
PMID:33859992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8042139/
Abstract

Increasing evidence supports a role of proximal tubular (PT) injury in the progression of diabetic kidney disease (DKD), in patients with or without proteinuria. Research on the mechanisms of the PT injury in DKD could help us to identify potential new biomarkers and drug targets for DKD. A high glucose transport state and mismatched local hypoxia in the PT of diabetes patients may be the initiating factors causing PT injury. Other mechanism such as mitochondrial dysfunction, reactive oxygen species (ROS) overproduction, ER stress, and deficiency of autophagy interact with each other leading to more PT injury by forming a vicious circle. PT injury eventually leads to the development of tubulointerstitial inflammation and fibrosis in DKD. Many downstream signaling pathways have been demonstrated to mediate these diseased processes. This review focuses mostly on the novel mechanisms of proximal renal tubular injury in DKD and we believe such review could help us to better understand the pathogenesis of DKD and identify potential new therapies for this disease.

摘要

越来越多的证据支持近端肾小管(PT)损伤在糖尿病肾病(DKD)进展中所起的作用,无论患者有无蛋白尿。对DKD中PT损伤机制的研究有助于我们识别DKD潜在的新生物标志物和药物靶点。糖尿病患者PT中高葡萄糖转运状态和局部缺氧不匹配可能是导致PT损伤的起始因素。其他机制,如线粒体功能障碍、活性氧(ROS)过度产生、内质网应激和自噬缺陷,相互作用,通过形成恶性循环导致更多的PT损伤。PT损伤最终导致DKD中肾小管间质炎症和纤维化的发展。许多下游信号通路已被证明介导这些疾病过程。本综述主要关注DKD中近端肾小管损伤的新机制,我们相信这样的综述有助于我们更好地理解DKD的发病机制,并确定该疾病潜在的新疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/394f/8042139/6517f4247f75/fmed-08-661076-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/394f/8042139/6517f4247f75/fmed-08-661076-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/394f/8042139/6517f4247f75/fmed-08-661076-g0001.jpg

相似文献

1
Update on the Mechanisms of Tubular Cell Injury in Diabetic Kidney Disease.糖尿病肾病中肾小管细胞损伤机制的最新进展
Front Med (Lausanne). 2021 Mar 30;8:661076. doi: 10.3389/fmed.2021.661076. eCollection 2021.
2
AKI-to-CKD transition is a potential mechanism for non-albuminuric diabetic kidney disease.急性肾损伤向慢性肾脏病的转变是非白蛋白尿性糖尿病肾病的一种潜在机制。
Fac Rev. 2022 Jul 28;11:21. doi: 10.12703/r/11-21. eCollection 2022.
3
Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives.糖尿病肾病中的管状损伤:分子机制和潜在的治疗前景。
Front Endocrinol (Lausanne). 2023 Aug 2;14:1238927. doi: 10.3389/fendo.2023.1238927. eCollection 2023.
4
The Mitochondria-Targeted Metabolic Tubular Injury in Diabetic Kidney Disease.糖尿病肾病中靶向线粒体的代谢性肾小管损伤
Cell Physiol Biochem. 2019;52(2):156-171. doi: 10.33594/000000011. Epub 2019 Feb 28.
5
Sacubitril/valsartan ameliorates tubulointerstitial fibrosis by restoring mitochondrial homeostasis in diabetic kidney disease.沙库巴曲缬沙坦通过恢复糖尿病肾病中的线粒体稳态来改善肾小管间质纤维化。
Diabetol Metab Syndr. 2024 Feb 10;16(1):40. doi: 10.1186/s13098-024-01284-1.
6
Mercapturate Pathway in the Tubulocentric Perspective of Diabetic Kidney Disease.巯基化途径在糖尿病肾病的管状中心观点中的作用。
Nephron. 2019;143(1):17-23. doi: 10.1159/000494390. Epub 2019 Jan 9.
7
Mitochondrial dysfunction in diabetic kidney disease.糖尿病肾病中的线粒体功能障碍。
Clin Chim Acta. 2019 Sep;496:108-116. doi: 10.1016/j.cca.2019.07.005. Epub 2019 Jul 2.
8
Deficiency of thiosulfate sulfurtransferase mediates the dysfunction of renal tubular mitochondrial fatty acid oxidation in diabetic kidney disease.硫代硫酸盐硫转移酶缺乏介导糖尿病肾病肾小管线粒体脂肪酸氧化功能障碍。
Cell Death Differ. 2024 Dec;31(12):1636-1649. doi: 10.1038/s41418-024-01365-8. Epub 2024 Aug 22.
9
SIK2 protects against renal tubular injury and the progression of diabetic kidney disease.SIK2可预防肾小管损伤及糖尿病肾病进展。
Transl Res. 2023 Mar;253:16-30. doi: 10.1016/j.trsl.2022.08.012. Epub 2022 Sep 6.
10
Protective Effect of Salidroside Against Diabetic Kidney Disease Through Inhibiting BIM-Mediated Apoptosis of Proximal Renal Tubular Cells in Rats.红景天苷通过抑制大鼠近端肾小管细胞中BIM介导的凋亡对糖尿病肾病的保护作用
Front Pharmacol. 2018 Dec 4;9:1433. doi: 10.3389/fphar.2018.01433. eCollection 2018.

引用本文的文献

1
Repurposing Diabetes Therapies in CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and GLP-1 RAs.慢性肾脏病中糖尿病治疗药物的重新利用:钠-葡萄糖协同转运蛋白2抑制剂和胰高血糖素样肽-1受体激动剂的作用机制、临床疗效及安全性
Pharmaceuticals (Basel). 2025 Jul 28;18(8):1130. doi: 10.3390/ph18081130.
2
Mitochondrial insights: key biomarkers and potential treatments for diabetic nephropathy and sarcopenia.线粒体洞察:糖尿病肾病和肌肉减少症的关键生物标志物及潜在治疗方法
Front Cell Dev Biol. 2025 Jul 9;13:1596204. doi: 10.3389/fcell.2025.1596204. eCollection 2025.
3
Regulation of pyroptosis in diabetic nephropathy by long non-coding and circular RNAs.

本文引用的文献

1
Acute Kidney Injury and Progressive Diabetic Kidney Disease: An Epidemiological Perspective.急性肾损伤与糖尿病肾病进展:流行病学视角
Int J Nephrol Renovasc Dis. 2021 Feb 9;14:23-31. doi: 10.2147/IJNRD.S291319. eCollection 2021.
2
Tumor necrosis factor-α blockade ameliorates diabetic nephropathy in rats.肿瘤坏死因子-α阻断可改善大鼠糖尿病肾病。
Clin Kidney J. 2019 Nov 7;14(1):301-308. doi: 10.1093/ckj/sfz137. eCollection 2021 Jan.
3
miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
长链非编码RNA和环状RNA对糖尿病肾病中细胞焦亡的调控
Clin Exp Med. 2025 Jun 18;25(1):208. doi: 10.1007/s10238-025-01740-w.
4
Proximal tubular deletion of superoxide dismutase-2 reveals disparate effects on kidney function in diabetes.近端肾小管超氧化物歧化酶-2缺失揭示了对糖尿病肾功能的不同影响。
Redox Biol. 2025 May;82:103601. doi: 10.1016/j.redox.2025.103601. Epub 2025 Mar 18.
5
Mechanisms, Biomarkers, and Treatment Approaches for Diabetic Kidney Disease: Current Insights and Future Perspectives.糖尿病肾病的发病机制、生物标志物及治疗方法:当前见解与未来展望
J Clin Med. 2025 Jan 23;14(3):727. doi: 10.3390/jcm14030727.
6
TRPC6-Calpain-1 Axis Promotes Tubulointerstitial Inflammation by Inhibiting Mitophagy in Diabetic Kidney Disease.TRPC6-钙蛋白酶-1轴通过抑制糖尿病肾病中的线粒体自噬促进肾小管间质炎症。
Kidney Int Rep. 2024 Aug 23;9(11):3301-3317. doi: 10.1016/j.ekir.2024.08.019. eCollection 2024 Nov.
7
Exercise as a therapeutic approach to alleviate diabetic kidney disease: mechanisms, clinical evidence and potential exercise prescriptions.运动作为缓解糖尿病肾病的治疗方法:作用机制、临床证据及潜在运动处方
Front Med (Lausanne). 2024 Oct 25;11:1471642. doi: 10.3389/fmed.2024.1471642. eCollection 2024.
8
Mechanisms of hepatic and renal injury in lipid metabolism disorders in metabolic syndrome.代谢综合征中脂质代谢紊乱导致的肝肾功能损伤机制。
Int J Biol Sci. 2024 Sep 9;20(12):4783-4798. doi: 10.7150/ijbs.100394. eCollection 2024.
9
MicroRNA-630: A potential guardian against inflammation in diabetic kidney disease.微小RNA-630:糖尿病肾病炎症的潜在守护者。
World J Diabetes. 2024 Sep 15;15(9):1837-1841. doi: 10.4239/wjd.v15.i9.1837.
10
Targeting senescence to prevent diabetic kidney disease: Exploring molecular mechanisms and potential therapeutic targets for disease management.靶向衰老以预防糖尿病肾病:探索疾病管理的分子机制和潜在治疗靶点。
Diabet Med. 2025 Feb;42(2):e15408. doi: 10.1111/dme.15408. Epub 2024 Jul 12.
miR-30b-5p 通过直接靶向 SNAI1 调节糖尿病肾病中的肾上皮-间充质转化。
Biochem Biophys Res Commun. 2021 Jan 8;535:12-18. doi: 10.1016/j.bbrc.2020.10.096. Epub 2020 Dec 29.
4
Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway.微小 RNA-98 的减少通过升高 Nedd4L 并抑制 TGF-β/Smad2/3 通路减轻糖尿病肾病中的肾纤维化。
Cell Cycle. 2020 Dec;19(24):3406-3418. doi: 10.1080/15384101.2020.1838780. Epub 2020 Dec 14.
5
Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 NF-κB and STAT3.多硫化物介导的 SIRT1 巯基化通过抑制 p65 NF-κB 和 STAT3 的磷酸化和乙酰化来预防糖尿病肾病。
Redox Biol. 2021 Jan;38:101813. doi: 10.1016/j.redox.2020.101813. Epub 2020 Nov 25.
6
Protective effect of carnosine on hydrogen peroxide-induced oxidative stress in human kidney tubular epithelial cells.肌肽对人肾小管上皮细胞双氧水诱导氧化应激的保护作用。
Biochem Biophys Res Commun. 2021 Jan 1;534:576-582. doi: 10.1016/j.bbrc.2020.11.037. Epub 2020 Dec 1.
7
Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis.肌肽通过靶向 GNMT(一种介导肾脏炎症和纤维化的关键酶)来缓解糖尿病肾病。
Clin Sci (Lond). 2020 Dec 11;134(23):3175-3193. doi: 10.1042/CS20201207.
8
ATF4 promotes renal tubulointerstitial fibrosis by suppressing autophagy in diabetic nephropathy.转录激活因子 4 通过抑制自噬促进糖尿病肾病肾小管间质纤维化。
Life Sci. 2021 Jan 1;264:118686. doi: 10.1016/j.lfs.2020.118686. Epub 2020 Oct 28.
9
MicroRNA‑199a‑3p suppresses high glucose‑induced apoptosis and inflammation by regulating the IKKβ/NF‑κB signaling pathway in renal tubular epithelial cells.微小 RNA-199a-3p 通过调节肾近端小管细胞中 IKKβ/NF-κB 信号通路抑制高糖诱导的细胞凋亡和炎症。
Int J Mol Med. 2020 Dec;46(6):2161-2171. doi: 10.3892/ijmm.2020.4751. Epub 2020 Oct 12.
10
Acute Kidney Injury: A Bona Fide Complication of Diabetes.急性肾损伤:糖尿病的一种真正并发症。
Diabetes. 2020 Nov;69(11):2229-2237. doi: 10.2337/db20-0604.